Avagliano Mark

Chief Business Officer at G1 Therapeutics, Inc.

Sold, on record
$74k
Dollars the filings state
Form 4 sales
4
Latest Jul 5, 2024
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale G1 Therapeutics, Inc.Plan not stated
    Jan 5, 2022 2022

    Sold 1,445 shares at $10.61 ($15k)

    Avagliano Mark, Chief Business Officer

    Sold 6.3% of holdings ($244k position)21,555 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale G1 Therapeutics, Inc.No plan
    Jan 4, 2024 +729 days

    Sold 4,081 shares at $3.09 ($13k)

    Avagliano Mark, Chief Business Officer

    No 10b5-1 planSold 3.3% of holdings ($376k position)117,834 shares leftFiling

  3. 3 Form 4 sale G1 Therapeutics, Inc.No plan
    May 13, 2024 +130 days

    Sold 8,151 shares at $4.79 ($39k)

    Avagliano Mark, Chief Business Officer

    No 10b5-1 planSold 3.7% of holdings ($1M position)209,683 shares leftFiling

  4. 4 Form 4 sale G1 Therapeutics, Inc.No plan
    Jul 5, 2024 +53 days

    Sold 2,638 shares at $2.51 ($7k)

    Avagliano Mark, Chief Business Officer

    No 10b5-1 planSold 1.1% of holdings ($614k position)242,045 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Avagliano Mark
Source
Jul 5, 2024Jul 8, 2024G1 Therapeutics, Inc.Chief Business OfficerForm 4 sale2,638$7k1.1%No planSEC
May 13, 2024May 15, 2024G1 Therapeutics, Inc.Chief Business OfficerForm 4 sale8,151$39k3.7%No planSEC
Jan 4, 2024Jan 8, 2024G1 Therapeutics, Inc.Chief Business OfficerForm 4 sale4,081$13k3.3%No planSEC
Jan 5, 2022Jan 5, 2022G1 Therapeutics, Inc.Chief Business OfficerForm 4 sale1,445$15k6.3%Plan not statedSEC